Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality
Related Experiment Video
Updated: Mar 7, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Thomas Zegkos1, Georgios K Efthimiadis1, Despoina G Parcharidou1
11(st) Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Insights
Atrial fibrillation (AF) significantly increases mortality in hypertrophic cardiomyopathy (HCM) patients. Larger left atrial size predicts both AF and stroke, highlighting its prognostic importance in HCM management.
Area of Science:
- Cardiology
- Internal Medicine
- Genetics
Background:
- Atrial fibrillation (AF) is a common arrhythmia in hypertrophic cardiomyopathy (HCM).
- Understanding the impact of AF on HCM prognosis is crucial for patient management.
Purpose of the Study:
- To investigate the clinical impact and prognostic significance of AF in a large cohort of HCM patients.
- To identify predictors of AF and thromboembolic stroke in HCM.
Main Methods:
- Retrospective analysis of 509 HCM patients.
- Evaluation of echocardiographic and clinical data.
- Assessment of AF, stroke risk factors, and mortality outcomes.
Main Results:
- 23.4% of HCM patients had AF, with higher stroke prevalence and worse functional status.
- Left atrial (LA) size independently predicted AF and stroke.
- AF was a significant risk factor for overall, HCM-related, and heart failure-related mortality, but not sudden death.
Conclusions:
- LA size is a key predictor for both AF and thromboembolic stroke in HCM.
- AF is associated with substantially increased mortality rates in HCM patients, irrespective of AF type.
Background:
Atrial fibrillation (AF) is the most common arrhythmic event in patients with hypertrophic cardiomyopathy (HCM). The aim of this study was to identify the clinical impact and prognostic significance of AF on a large cohort of patients with HCM.
Methods:
Echocardiographic and clinical correlates, risk factors for AF and thromboembolic stroke and the prognostic significance of AF were evaluated in 509 patients with an established diagnosis of HCM.
Results:
A total of 119 patients (23.4%) were diagnosed with AF during the index evaluation visit. AF patients had a higher prevalence of stroke and presented with worse functional impairment. Left atrial diameter (LA size) was a common independent predictor of the arrhythmia (OR: 2.2, 95% CI 1.6-3.3) and thromboembolic stroke (OR: 1.6, 95% CI 1.01-2.40). AF was an important risk factor for overall mortality (HR=3.4, 95% CI: 1.7-6.5), HCM-related mortality (HR=3.9, 95% CI: 1.8-8.2) and heart failure-related mortality (HR=6.0, 95% CI: 2.0-17.9), even after adjusting for statistically significant clinical and demographic risk factors. However, AF did not affect the risk for sudden death.
Conclusions:
LA size is an independent predictor of both AF and thromboembolic stroke. Moreover, patients with AF, regardless of type, have significantly higher mortality rates than patients without AF.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy

